Joinn Laboratories(China)Co.,Ltd. (603127.SS)
CNY 15.59
(0.65%)
CNY 15.59
(0.65%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.02 Billion CNY | -3.25% |
| 2022 | 10.36 Billion CNY | 21.4% |
| 2021 | 8.53 Billion CNY | 305.02% |
| 2020 | 2.1 Billion CNY | 48.66% |
| 2019 | 1.41 Billion CNY | 24.22% |
| 2018 | 1.14 Billion CNY | 21.31% |
| 2017 | 940.87 Million CNY | 57.58% |
| 2016 | 597.06 Million CNY | 23.88% |
| 2015 | 481.98 Million CNY | 6.7% |
| 2014 | 451.7 Million CNY | 18.84% |
| 2013 | 380.09 Million CNY | 0.01% |
| 2012 | 380.05 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 9.52 Billion CNY | -1.41% |
| 2024 Q1 | 9.73 Billion CNY | -2.93% |
| 2024 Q2 | 9.66 Billion CNY | -0.74% |
| 2023 Q4 | 10.02 Billion CNY | -2.01% |
| 2023 Q1 | 10.54 Billion CNY | 1.77% |
| 2023 FY | 10.02 Billion CNY | -3.25% |
| 2023 Q3 | 10.23 Billion CNY | 0.13% |
| 2023 Q2 | 10.21 Billion CNY | -3.12% |
| 2022 Q4 | 10.36 Billion CNY | 2.83% |
| 2022 FY | 10.36 Billion CNY | 21.4% |
| 2022 Q3 | 10.07 Billion CNY | -5.33% |
| 2022 Q2 | 10.64 Billion CNY | 18.86% |
| 2022 Q1 | 8.95 Billion CNY | 4.92% |
| 2021 Q3 | 8.2 Billion CNY | 4.23% |
| 2021 Q1 | 7.63 Billion CNY | 262.17% |
| 2021 FY | 8.53 Billion CNY | 305.02% |
| 2021 Q2 | 7.86 Billion CNY | 3.08% |
| 2021 Q4 | 8.53 Billion CNY | 4.09% |
| 2020 FY | 2.1 Billion CNY | 48.66% |
| 2020 Q3 | 1.79 Billion CNY | 4.58% |
| 2020 Q4 | 2.1 Billion CNY | 17.12% |
| 2020 Q2 | 1.72 Billion CNY | 7.52% |
| 2020 Q1 | 1.6 Billion CNY | 12.89% |
| 2019 Q1 | 1.18 Billion CNY | 3.69% |
| 2019 FY | 1.41 Billion CNY | 24.22% |
| 2019 Q4 | 1.41 Billion CNY | 6.56% |
| 2019 Q3 | 1.33 Billion CNY | 6.56% |
| 2019 Q2 | 1.24 Billion CNY | 5.5% |
| 2018 Q4 | 1.14 Billion CNY | 3.92% |
| 2018 Q2 | 1 Billion CNY | 3.08% |
| 2018 Q1 | 978.8 Million CNY | 4.03% |
| 2018 FY | 1.14 Billion CNY | 21.31% |
| 2018 Q3 | 1.09 Billion CNY | 8.85% |
| 2017 Q2 | 630.7 Million CNY | 0.0% |
| 2017 Q3 | 896.47 Million CNY | 42.14% |
| 2017 FY | 940.87 Million CNY | 57.58% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q4 | 940.87 Million CNY | 4.95% |
| 2016 FY | 597.06 Million CNY | 23.88% |
| 2016 Q4 | 597.06 Million CNY | 0.0% |
| 2015 FY | 481.98 Million CNY | 6.7% |
| 2014 FY | 451.7 Million CNY | 18.84% |
| 2013 FY | 380.09 Million CNY | 0.01% |
| 2012 FY | 380.05 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 14.3 Billion CNY | 29.929% |
| WuXi AppTec Co., Ltd. | 74.26 Billion CNY | 86.498% |
| Autobio Diagnostics Co., Ltd. | 11.55 Billion CNY | 13.215% |
| Thalys Medical Technology Group Inc. | 3.34 Billion CNY | -200.054% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 11.76 Billion CNY | 14.791% |
| Chemclin Diagnostics Co., Ltd. | 1.82 Billion CNY | -450.773% |